Juan José Soto-Castillo

7PUBLICATIONS
43CO-AUTHORS
Molecular targetsCardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 25, 2025
Author Correction: Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours.

Ignacio Melero, Maria de Miguel Luken, Guillermo de Velasco

|Dec 11, 2024
Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours.

Ignacio Melero, Maria de Miguel Luken, Guillermo de Velasco

|Jul 14, 2023
SWI/SNF Complex Alterations in Tumors with Rhabdoid Features: Novel Therapeutic Approaches and Opportunities for Adoptive Cell Therapy.

Juan José Soto-Castillo, Lucía Llavata-Marti, Roser Fort-Culillas

|Jun 10, 2022
When Less May Be Enough: Dose Selection Strategies for Immune Checkpoint Inhibitors Focusing on AntiPD-(L)1 Agents.

Daniel V Araujo, Bruno Uchoa, Juan José Soto-Castillo

|Jul 26, 2021
Management of Intracranial Metastases in EGFR-Mutated NSCLC: A Review of Literature following an Unusual Case Report.

Víctor Albarrán, Javier Pozas, Juan José Soto

|Nov 17, 2020
Tyrosine Kinase Receptors in Oncology.

Jorge Esteban-Villarrubia, Juan José Soto-Castillo, Javier Pozas

Pageof 2